Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial
Le Page, Emmanuelle, MD ; Veillard, David, MD ; Laplaud, David A, Prof ; Hamonic, Stéphanie, MSc ; Wardi, Rasha, MD ; Lebrun, Christine, MD ; Zagnoli, Fabien, MD ; Wiertlewski, Sandrine, MD ; Deburghgraeve, Véronique, MD ; Coustans, Marc, MD ; Edan, Gilles, Prof
The Lancet (British edition), 2015-09, Vol.386 (9997), p.974-981 [Periódico revisado por pares]England: Elsevier Ltd
Texto completo disponível